The effect of intranasally administered TLR3 agonist larifan on metabolic profile of microglial cells in rat with C6 glioma

Glioma-associated microglia/macrophages (GAM) represent an attractive therapeutic target for the development of the alternative methodology in the treatment of gliomas. This study was aimed to investigate the effect of intranasally administered TLR3 agonist Larifan on microglial cell metabolic profi...

Full description

Bibliographic Details
Main Authors:	Y. Hurmach, M. Rudyk, V. Svyatetska, N. Senchylo, O. Skachkova, D. Pjanova, K. Vaivode, L. Skivka
Format:	Article
Language:	English
Published:	National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2018-11-01
Series:	The Ukrainian Biochemical Journal
Subjects:	glioma immunotherapy microglia toll-like receptor agonist
Online Access:	http://ukrbiochemjournal.org/wp-content/uploads/2018/11/Hurmach_6.pdf

Similar Items

POLARIZED ACTIVATION OF HUMAN PERIPHERAL BLOOD PHAGOCYTES BY BACTERIOPHAGE–DERIVED DOUBLE-STRANDED RNA (LARIFAN) IN VITRO
by: R. Dovhyi, et al.
Published: (2023-12-01)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
by: Hong Liang, et al.
Published: (2022-11-01)

The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview
by: Irene Veneziani, et al.
Published: (2022-12-01)

Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment
by: Graham Thomas, et al.
Published: (2021-07-01)

MICROGLIAL PHAGOCYTOSIS IN RATS WITH DIFFERENT MODELS OF ALZHEIMER'S DISEASE
by: A. Nefedova, et al.
Published: (2023-02-01)

EFFECT OF INTRACRANIAL CATHETER PLACEMENT ON MICROGLIA METABOLIC PROFILE OF RATS
by: Y. Hurmach, et al.
Published: (2018-08-01)

miR-154-5p Is a Novel Endogenous Ligand for TLR7 Inducing Microglial Activation and Neuronal Injury
by: Hugo McGurran, et al.
Published: (2024-02-01)

Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer’s Disease
by: Weigang Cui, et al.
Published: (2020-05-01)

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
by: Allison M. Owen, et al.
Published: (2021-02-01)

pKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain
by: Sehwan Kim, et al.
Published: (2023-03-01)

Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-09-01)

A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model
by: Yunlong Hu, et al.
Published: (2020-03-01)

TLR1/2 Specific Small‐Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes
by: Xiaohong Cen, et al.
Published: (2019-05-01)

A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
by: Huju Chi, et al.
Published: (2022-06-01)

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure
by: Caroline Thue Hvilsom, et al.
Published: (2021-09-01)

Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation
by: Bailey A. Loving, et al.
Published: (2021-01-01)

Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies
by: Marija Rozman, et al.
Published: (2023-01-01)

Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia
by: James A. Carroll, et al.
Published: (2021-09-01)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022-06-01)

Dexmedetomidine inhibits the lipopolysaccharide‐stimulated inflammatory response in microglia through the pathway involving TLR4 and NF‐κB
by: Xue‐Yue Zhou, et al.
Published: (2019-12-01)

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
by: Linda K. Curtiss, et al.
Published: (2012-10-01)

Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid
by: Rui Zhou, et al.
Published: (2015-09-01)

Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
by: Sashi Debnath, et al.
Published: (2022-06-01)

Microglial activation by microbial neuraminidase through TLR2 and TLR4 receptors
by: María del Mar Fernández-Arjona, et al.
Published: (2019-12-01)

Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia
by: Yao Linli, et al.
Published: (2013-02-01)

Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
by: Greiff Lennart, et al.
Published: (2012-06-01)

TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization
by: Sylvain Thierry, et al.
Published: (2023-04-01)

TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
by: Yongji Zhou, et al.
Published: (2020-12-01)

Propofol and α2-Agonists Attenuate Microglia Activation and Restore Mitochondrial Function in an In Vitro Model of Microglia Hypoxia/Reoxygenation
by: Lucia Longhitano, et al.
Published: (2022-08-01)

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
by: Floriane Auderset, et al.
Published: (2019-07-01)

Environmental stimuli shape microglial plasticity in glioma
by: Stefano Garofalo, et al.
Published: (2017-12-01)

Therapeutic Effects of ADU-S100 as STING Agonist and CpG ODN1826 as TLR9 Agonist in CT-26 Model of Colon Carcinoma
by: Sare Hajiabadi, et al.
Published: (2023-07-01)

Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma
by: Myriam Catalano, et al.
Published: (2022-10-01)

The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice
by: Kim Thi Hoang Do, et al.
Published: (2023-10-01)

TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity
by: V. Alexandra Moser, et al.
Published: (2018-11-01)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
by: Huju Chi, et al.
Published: (2017-05-01)

TLR9/NF-kB Pathway Regulates Brucella CpG DNA-mediated Cytokine Response in Human Peripheral Blood Mononuclear Cells
by: Yunzhi Peng, et al.
Published: (2021-12-01)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
by: Kamel Chettab, et al.
Published: (2023-05-01)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
by: Marina Luchner, et al.
Published: (2021-01-01)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
by: Kuan-Yin Shen, et al.
Published: (2020-03-01)